Yutaka Ohuchi

Title: Yutaka Ohuchi: Innovator in Pharmaceutical Chemistry

Introduction

Yutaka Ohuchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target gastrointestinal conditions. With a total of 8 patents to his name, Ohuchi's work has had a notable impact on medical science.

Latest Patents

One of his latest patents involves quinolinecarboxylic acid derivatives, specifically a heterocyclic compound known as Endo-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl) 1-isopropyl-2(1H)-quinolone-3-carboxylate. This compound acts on the serotonin 4 receptor, exhibiting serotonin-like receptor stimulating activity. As a result, it plays a crucial role in activating gastrointestinal motor functions, making it effective for improving conditions such as heartburn, anorexia, bowel pain, and abdominal distension associated with chronic gastritis or postoperative gastroparesis. Furthermore, it is beneficial for treating gastro-esophageal reflux, intestinal pseudo-obstruction, and constipation.

Career Highlights

Throughout his career, Yutaka Ohuchi has worked with notable companies, including Taisho Pharmaceutical Co., Ltd. and Kuraray Co., Ltd. His expertise in pharmaceutical chemistry has allowed him to develop innovative solutions that address various health issues.

Collaborations

Ohuchi has collaborated with esteemed colleagues, including Katsuo Hatayama and Kensei Yoshikawa. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Yutaka Ohuchi's contributions to pharmaceutical chemistry and his innovative patents have significantly advanced the treatment of gastrointestinal conditions. His work continues to influence the field and improve patient outcomes.